Effect of Low-Pathogenic Human Coronavirus-Specific Antibodies on SARS-CoV-2

Documenti analoghi

• Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
  di: Jiang, Shibo, et al.
  Pubblicazione: (2020)
• Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC
  di: Du, Lanying, et al.
  Pubblicazione: (2013)
• Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses: (Trends in Immunology 41, 355–359; 2020)
  di: Jiang, Shibo, et al.
  Pubblicazione: (2020)
• From SARS-CoV to SARS-CoV-2: safety and broad-spectrum are important for coronavirus vaccine development
  di: Ma, Cuiqing, et al.
  Pubblicazione: (2020)
• Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
  di: Tai, Wanbo, et al.
  Pubblicazione: (2020)